enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Tolvaptan - Wikipedia

    en.wikipedia.org/wiki/Tolvaptan

    Tolvaptan, sold under the brand name Samsca among others, is an aquaretic drug that functions as a selective, competitive vasopressin receptor 2 (V 2) antagonist used to treat hyponatremia (low blood sodium levels) associated with congestive heart failure, cirrhosis, and the syndrome of inappropriate antidiuretic hormone (SIADH).

  3. Vasopressin receptor antagonist - Wikipedia

    en.wikipedia.org/wiki/Vasopressin_receptor...

    It has been suggested that cardiovascular mortality may be reduced by selective V 2 RA such as tolvaptan in the higher risk group with kidney function impairment or severe congestive findings. [9] But until FDA indication is granted for use in CHF with or without accompanying hyponatremia, VRAs are not recommended in patients with CHF. [9]

  4. Tolvaptan phosphate - Wikipedia

    en.wikipedia.org/wiki/Tolvaptan_phosphate

    It is a prodrug of tolvaptan, [1] [2] formulated as the salt tolvaptan sodium phosphate, for intravenous administration. Tolvaptan phosphate is converted into the active drug tolvaptan in the human body following administration. It was developed by Otsuka Pharmaceutical Co. and was approved for use in Japan in 2022. [3]

  5. Conivaptan - Wikipedia

    en.wikipedia.org/wiki/Conivaptan

    Conivaptan, sold under the brand name Vaprisol, is a non-peptide inhibitor of the receptor for anti-diuretic hormone, also called vasopressin.It was approved in 2004 for hyponatremia (low blood sodium levels).

  6. AOL Mail

    mail.aol.com

    Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!

  7. Autosomal dominant polycystic kidney disease - Wikipedia

    en.wikipedia.org/wiki/Autosomal_dominant...

    In 2014, Japan was the first country in the world to approve a pharmacological treatment for ADPKD [33] followed by Canada and Europe, which approved the drug tolvaptan for ADPKD patients in the beginning of 2015. The USA FDA approved the use of tolvaptan in the treatment of ADPKD in 2018. [41]

  8. ATC code C03 - Wikipedia

    en.wikipedia.org/wiki/ATC_code_C03

    ATC code C03 Diuretics is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.

  9. AOL Mail - AOL Help

    help.aol.com/products/aol-webmail

    Get answers to your AOL Mail, login, Desktop Gold, AOL app, password and subscription questions. Find the support options to contact customer care by email, chat, or phone number.